Fundamentals data is not available for this company.
| Year Ending | Revenue ($m) | Pre-tax ($m) | EPS | P/E | PEG | EPS Grth. | Div | Yield |
|---|---|---|---|---|---|---|---|---|
| 31-Dec-12 | 2.44 | (80.48) | (59.33)¢ | n/a | n/a | n/a | n/a | 0.0% |
| 31-Dec-13 | 4.46 | (91.32) | (65.00)¢ | n/a | n/a | n/a | n/a | 0.0% |
Copyright © 2012 FactSet Research Systems Inc. All rights reserved.
No recent information was found.
| Geron explains setback on stem cell study | 28-Aug-2009 | BayArea.com |
| Geron sees progress in stem-cell therapy | 27-Aug-2007 | BayArea.com |
| Stock Ticker | 12-Jun-2007 | BayArea.com |
| Currency | US Dollars |
| Share Price | $ 1.42 |
| Change Today | $ 0.03 |
| % Change | 2.16 % |
| 52 Week High | $4.45 |
| 52 Week Low | $1.37 |
| Volume | 369,563 |
| Shares Issued | 132.09m |
| Market Cap | $187.56m |
| Beta | 1.56 |
| RiskGrade | 218 |
| Strong Buy | 1 |
| Buy | 0 |
| Neutral | 2 |
| Sell | 0 |
| Strong Sell | 0 |
| Total | 3 |

| Time | Volume / Share Price |
| 16:00 | 23,833 @ $1.42 |
| 15:59 | 200 @ $1.42 |
| 15:59 | 131 @ $1.42 |
| 15:59 | 100 @ $1.42 |
| 15:59 | 100 @ $1.41 |
You are here: research